Association of Interleukin-6 Levels with Morbidity and Mortality in Patients with Coronavirus Disease 2019 (COVID-19)
-
- Zhou Jiali
- Department of Cardiology, Renmin Hospital of Wuhan University, People’s Republic of China
-
- He Wenbo
- Department of Cardiology, Renmin Hospital of Wuhan University, People’s Republic of China
-
- Liang Jingyu
- Department of Cardiology, Renmin Hospital of Wuhan University, People’s Republic of China
-
- Wang Lang
- Department of Cardiology, Renmin Hospital of Wuhan University, People’s Republic of China
-
- Yu Xiaomei
- Department of Cardiology, Renmin Hospital of Wuhan University, People’s Republic of China
-
- Bao Mingwei
- Department of Cardiology, Renmin Hospital of Wuhan University, People’s Republic of China
-
- Liu Huafen
- Department of Cardiology, Renmin Hospital of Wuhan University, People’s Republic of China
この論文をさがす
説明
<p>The prognostic value of interleukin-6 (IL-6) in coronavirus disease 2019 (COVID-19) needs to be clarified. In this retrospective study, COVID-19 patients treated at Renmin Hospital of Wuhan University from January 7 to February 8, 2020 with measurements of serum IL-6 levels within 1 week after admission were included. Data regarding demographics, clinical characteristics, laboratory tests, complications, and outcomes were collected and analyzed. Sixty-six patients diagnosed with COVID-19 were included in this study (31 patients were females). They were divided into a normal group (serum IL-6 <10 pg/mL, n = 35) and an abnormal group (serum IL-6 <10 pg/mL, n = 31). Compared with the normal group, the incidence of critical cases (P <0.001), acute respiratory distress syndrome (ARDS) (P = 0.001), acute cardiac injury (P = 0.002), cardiac insufficiency (P = 0.039), mechanical ventilation rate (P = 0.002), and mortality (P = 0.021) was significantly increased in the abnormal group. Serum IL-6 concentration was an independent predictor of fatal outcome (P = 0.04). The optimal cutoff value of serum IL-6 concentration for predicting fatal outcomes was 26.09 pg/mL (P <0.001). In COVID-19, elevated serum IL-6 levels were associated with critical illness, use of mechanical ventilation, and complications, including heart injury and ARDS, and could predict a fatal outcome. Early detection of serum IL-6 levels after admission should be necessary in COVID-19 patients.</p>
収録刊行物
-
- Japanese Journal of Infectious Diseases
-
Japanese Journal of Infectious Diseases 74 (4), 293-298, 2021-07-31
国立感染症研究所 Japanese Journal of Infectious Diseases 編集委員会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390007292691221248
-
- NII論文ID
- 130008066544
-
- NII書誌ID
- AA1132885X
-
- ISSN
- 18842836
- 13446304
-
- NDL書誌ID
- 031590124
-
- PubMed
- 33250487
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可